Latest News
European Brain Council in Davos During World Economic Forum 2026
From January 19-23, 2026, the European Brain Council (EBC) travelled to Davos, Switzerland for the World Economic Forum's Annual Meeting in order to engage with global leaders and decision-makers. EBC seized this opportunity to advance brain health as a fundamental pillar of economic prosperity through a series of strategic events and sessions, particularly through discussions focused on brain capital, [...]
January 2026: Start of the European Partnership for Brain Health!
January 2026 marks the official launch of the European Partnership for Brain Health (EP BrainHealth), following the two-year preparatory 'Coordination & Support Action (CSA) BrainHealth' project. EP BrainHealth is a major initiative involving over 55 partner institutions from more than 30 countries across Europe and beyond, co-funded by the European Commission. Launched in January 2026, EP BrainHealth is a [...]
EBC supports WHO’s historical declaration on noncommunicable diseases and mental health
The European Brain Council welcomes landmark commitment to integrated approach for NCDs and mental health. Last week, 175 UN Member States adopted the Political Declaration of the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs) and Mental Health – the first declaration to address NCDs and mental health together through a fully integrated approach, and crucially, the first to explicitly recognise [...]
EBC at the 2025 Sakharov Prize for Freedom of Thought Ceremony
The European Brain Council (EBC) attended the Sakharov Prize for Freedom of Thought ceremony yesterday at the European Parliament in Strasbourg, where the 2025 award was presented to Georgian journalist Mzia Amaglobeli and Belarusian journalist Andrzej Poczobut. Established by the European Parliament in 1988 and named after Russian physicist and human rights advocate Andrei Sakharov, the prize recognises individuals [...]
Event Highlights – Rethinking Schizophrenia in Denmark: Schizophrenia and Brain Health
Introduction Following the recommendations set out in the Rethinking Schizophrenia Care Pathway in Europe study paper, the next phase of the project — Country Profiles: Beyond Mental Health – A Brain Health Approach to Schizophrenia Prevention and Care — will focus on an in-depth analysis of country-specific models of care. After a roundtable meeting in Poland on 5 June 2025, we are [...]
EBC Endorses the Rett Syndrome White Paper
EBC endorses the White Paper, Building Coordinated Care Pathways for Rett Syndrome: A Call to Action in Europe, co-authored by Charles River Associates, Rett Syndrome Europe and Acadia Pharmaceuticals Inc. with a special foreword from MEP Tom Sokol, which is now available to the public! This marks an important step in advancing the conversation around improving care coordination for [...]
EBC Endorses “European Migraine and Headache Alliance (EMHA) Roadmap 2025”
The European Brain Council (EBC) is pleased to announce its endorsement of the “European Migraine and Headache Alliance (EMHA) Roadmap 2025”, a major new initiative to advance migraine awareness, research, and policy at the European level. Migraine is a complex and disabling neurological condition affecting more than 41 million adults across the EU, and remains one of the most [...]
Letter from the President – Fall 2025
Dear EBC Members, Partners and Community, As we approach EBC's General Assembly, I would like to take a moment to reflect on what we have accomplished together and report on a few highlights through this letter. The past months have been marked by crucial milestones for EBC. The 2025 Brain Innovation Days brought together researchers, industry leaders, patients, [...]
The Brain as a Strategic Asset: Securing Europe’s Future Through Innovation and Health
Policy Opening of the Brain Innovation Days 2025 The Brain as a Strategic Asset: Securing Europe’s Future Through Innovation & Health 14th of October, 2025, European Parliament The event “The Brain as a Strategic Asset: Securing Europe’s Future Through Innovation and Health” brought together Members of the European Parliament, scientists, patient representatives, and industry [...]
EBC at the European College of Neuropsychopharmacology (ECNP) Congress – Amsterdam 2025
The European College of Neuropsychopharmacology (ECNP) held its annual Congress from 11 to 14 October 2025 in Amsterdam, gathering over 7,000 attendees including psychiatrists, neuroscientists, neurologists, psychologists and industry experts. Participants explored the latest research, treatments and technologies shaping the future of applied brain science through a rich programme of poster sessions, symposia, panel discussions, industry events, campfire [...]